The muscle question was settled in the 1990s. The 25g claim comes from brain research, and once you read those papers the recommendation changes shape entirely.
Key Points
Muscle creatine has a hard ceiling, and 3 to 5g/day fills it, so extra grams do nothing there (Hultman et al., 1996).
The brain is the real argument, because the blood-brain barrier admits creatine slowly and grudgingly (Braissant, 2012).
Even 20g/day for four straight weeks raises brain creatine by only about 9 percent (Dechent et al., 1999).
The famous 25 g study was a single dose given to 15 people during 21 hours of forced sleep deprivation, not a daily habit (Gordji-Nejad et al., 2024).
The only trial that ran 10 g and 20 g daily against placebo for six weeks in healthy young adults found nothing (Moriarty et al., 2023).
Introduction
A client asked me last month whether he should be taking five scoops of creatine instead of one. He had heard it on a podcast. Within two weeks, three more people asked the same question, which is usually the sign that a claim has escaped the research literature and gone feral on the internet.
The claim goes roughly like this: 5g/day is the legacy dose from 1990s bodybuilding research, it was only ever about muscle, and now that we know creatine does things for the brain, the real dose is 10, 20, or even 25g/day. Darren Candow, who is a genuinely serious creatine researcher and not a supplement salesman, has said publicly that he takes around 10g/day at baseline and goes to 20g when he is sleep deprived or traveling.
So this is not bro-science. There is a real scientific argument underneath it. But there is also a large gap between the argument and the way it is being repeated, and the gap is where people end up spending five times as much money for an effect nobody has measured.
I went and read the actual papers. Here is what they say, what they do not say, and what I think a reasonable person should do about it.
The Part That Is Actually Settled: Your Muscle Is a Bucket With a Lid
Skeletal muscle stores creatine as free creatine and phosphocreatine, and that store has a physical ceiling of roughly 150 to 160 mmol/kg dry mass. Most untrained omnivores sit around 120 to 125 mmol/kg dm at baseline, which is why supplementation works at all: there is headroom, but not much.
Harris et al. (1992) established that repeated 5 g doses could raise muscle total creatine by about 20 to 25 mmol/kg dm. Hultman et al. (1996) then ran the experiment that ended the dosing debate. One group loaded at 20 g/day for six days and then dropped to 2 g/day. Another group took 3 g/day for 28 days and never loaded at all. Both groups landed at the same muscle creatine concentration. Loading changed how fast you got there. It did not change where you ended up.
This is the single most important fact in the whole conversation, and it is 30 years old. A saturated muscle cannot hold more creatine. Once you are full, additional grams are either excreted in the urine or sitting in your gut drawing water.
| Protocol | Time to Saturation | End Point | Notes |
|---|---|---|---|
| 20 g/day x 5-6 days, then 2-5 g/day | ~1 week | Ceiling | Fastest. Highest GI risk during load. |
| 3-5 g/day, no loading | ~4 weeks | Ceiling | Same destination, slower arrival. |
| 10-25 g/day sustained | ~1 week | Ceiling | No additional muscle storage. Excess is excreted. |
Two wrinkles worth knowing. First, roughly 20 to 30 percent of people are functional non-responders, largely because they already sit close to the ceiling from a meat-heavy diet. Vegetarians and vegans sit lowest at baseline and respond most. Second, maintenance requirement scales with pool size: you replace roughly 1.5 to 2 percent of the pool per day, so a 110 kg lifter with a large lean mass genuinely needs more than a 55 kg one. That is an argument for 0.03 to 0.05 g/kg/day, which lands around 3 to 5 g for most people and maybe 8 g for a very large athlete. It is not an argument for 25 g.
The muscle side got a complication in 2025. Desai et al. randomized 63 people to 5 g/day or control across a 7-day wash-in plus 12 weeks of supervised resistance training. The wash-in produced 0.51 kg more lean body mass in the creatine group, which is the water shift everyone argues about. Over the 12 training weeks, both groups gained about 2 kg of lean mass with no difference between them (p = 0.71). The authors' own conclusion was that a maintenance dose above 5 g/day may be needed to augment lean mass growth. That is one trial, it used DXA, and it is at odds with a large body of prior work. But it is the closest thing the higher-dose-for-muscle camp has to direct evidence, and it is worth being honest that it exists.
So Why Is Anyone Talking About 25 Grams? Because the Brain Is Not the Muscle
Here is the legitimate part of the argument. Creatine does not enter the brain the way it enters muscle. The blood-brain barrier expresses the creatine transporter SLC6A8 on its endothelial cells, but permeability is low, and the surrounding astrocytes do not express it at all. The brain compensates by synthesizing a substantial fraction of its own creatine using AGAT and GAMT (Braissant, 2012).
Practically, that means oral creatine hits your muscle easily and your brain reluctantly. So if the target organ is the brain, the muscle dose is not automatically the right dose. That reasoning is sound. The question is what the measurements actually show.
| Study | Dose & Duration | n | Brain Creatine Change |
|---|---|---|---|
| Dechent et al. (1999) | 4 x 5 g/day (20 g) x 4 weeks | 6 | +8.7% average; white matter +11.5%, gray matter +4.7%, cerebellum +5.4% |
| Turner et al. (2015) | 20 g/day x 7 days | 15 | +9.2% in left precentral gyrus |
| Kondo et al. (2016) | 2 g / 4 g / 10 g per day x 8 weeks | 28 | Frontal phosphocreatine +4.6% / +4.1% / +9.1%; placebo -0.7%; not statistically significant |
Look at what those numbers do. Twenty grams a day for a month buys you an 8.7 percent rise in brain creatine. Twenty grams a day for a week buys you 9.2 percent. Ten grams a day for eight weeks buys you 9.1 percent in the frontal lobe, and the dose-response across 2, 4 and 10 g did not reach significance (p = 0.69) in a sample of 28.
Compare that to muscle, where a week of loading moves you 15 to 20 percent. The brain is a much harder target, the effect saturates in the single digits, and the dose-response curve above 10 g has essentially never been mapped in healthy people. Every honest review of this literature, including Candow et al. (2025), says the same thing: brain creatine responds to higher and longer dosing, and the biodynamics above 20 g/day are unknown.
He is candid that he does not know why it works, listing motor learning, reduced inhibition from the Golgi tendon organs and better neural coordination as possibilities before adding, "Or the effect could be psychological." He sizes the effect honestly too: "It's not a giant training effect, but it is something meaningful for a competitive lifter." And he treats it as a short-term tool, "a method that should only be used for a couple of weeks at a time" (Tuchscherer, 2016).
Christian Thibaudeau (2018) loads releasers differently depending on the goal. For overall strength he uses a combined eccentric of 110 to 120 percent of max, with the bar around 80 to 85 percent, doing one slow eccentric rep with the releasers followed by one to three normal reps. For muscle building he drops the bar to about 70 percent with a combined eccentric of 90 to 100 percent, re-hanging the releasers every rep with partners or in clusters, for sets of five. For power he uses a 60 percent bar, as much as another 60 percent on the releasers, and a fast but controlled eccentric.
That spread is typical. In a 2026 survey of 106 strength and conditioning practitioners about AEL for power development, 62 percent reported using it, most often once or twice a week at low volumes of one to three sets of four to six reps, and the most commonly reported limitation was fatigue and recovery demand (Bright et al., 2026).
The strongest counterargument is about muscle growth. Wolf (2025) concludes that "from a hypertrophy perspective, accentuated eccentric loading is a solution in search of a problem," because normal training already provides enough eccentric stimulus. That matches the pooled muscle-size data above. It is not an argument against a small strength or power effect, and some of the studies Wolf cites report exactly that.
The Study Behind the Headline
Nearly every version of the superdosing claim traces back to one paper: Gordji-Nejad et al. (2024) in Scientific Reports. It is a good study and it is being cited for something it did not test.
Fifteen healthy young adults, average age 23, were kept awake for 21 hours in a lab on two separate nights in a double-blind crossover. On one night they received a single oral dose of creatine monohydrate at 0.35 g/kg, which is about 25 g for a 70 kg person. On the other night, placebo. Creatine partially preserved brain phosphocreatine and ATP, and it blunted the sleep-deprivation-driven decline in processing speed, working memory, and psychomotor vigilance. Effects showed up in the hours after dosing.
The follow-up (Gordji-Nejad et al., 2026) replicated the design in 29 subjects at a lower single dose of 0.2 g/kg, about 14 g for a 70 kg person, and again saw a mitigating effect on sleep-deprivation-induced cognitive decline.
Read the design again. This is an acute rescue dose under an acute metabolic stressor, taken once, in a lab, in people whose brains were being deliberately depleted. It is closer in spirit to caffeine on a night shift than to a daily vitamin. Nothing in either paper tests, or claims to test, whether taking 25 g every morning for a year does anything for a well-rested person.
The same logic applies to Turner et al. (2015), the other paper people cite. They loaded 20 g/day for a week, then put subjects in a 10 percent oxygen mixture for 90 minutes. Creatine restored attentional capacity and increased corticomotor excitability under hypoxia. The stressor is the whole point. Remove the stressor and you remove the effect you were measuring.
What Happens When You Actually Take 10 to 20 g Daily? Somebody Checked
This is the part that gets left out of the podcast summaries. Moriarty et al. (2023) ran the direct test: 30 healthy young adults, double-blind, randomized to 10 g/day, 20 g/day, or placebo for six weeks, with processing speed, episodic memory, and executive function measured alongside prefrontal cortex oxygenation via fNIRS.
The result was nothing. No cognitive improvement at either dose. No dose-response. The authors' conclusion, verbatim, was that six weeks of creatine at a moderate or high dose does not improve cognitive performance or change prefrontal activation in healthy young adults.
That is a small study and a null result, and null results in small samples prove less than people want them to. But it is the most direct experiment anyone has run on the actual proposition, and it came back empty.
The broader meta-analytic picture is mixed and messier than the headlines. Prokopidis et al. (2023) pooled eight RCTs and found a small benefit for memory (SMD = 0.29, 95% CI 0.04 to 0.53), concentrated in older adults aged 66 to 76, with high heterogeneity (I2 = 66%). Crucially for our question, dose across the range of 2.2 to 20 g/day did not moderate the effect. That meta-analysis also drew a published letter to the editor arguing that double-counting in the statistics produced a false-positive, which is worth knowing before you lean on it.
On the muscle and strength side in older adults, Forbes et al. (2021) is the closest thing to a dose comparison. Higher-dose creatine (above 5 g/day) produced about 1.21 kg of lean tissue mass versus placebo; lower-dose (5 g/day or less) produced about 1.40 kg. Both significant, and the lower dose was numerically better. Where higher dosing did separate was leg press strength, which improved with the higher-dose protocols and not with the lower-dose ones. That is a narrow, subgroup-specific win in an older population, not a general mandate.
| Outcome | Is more than 5 g/day better? | Evidence quality |
|---|---|---|
| Muscle creatine storage | No. Hard ceiling. | Strong, settled since 1996 |
| Lean mass with training | No clear benefit; one 2025 trial hints yes | Weak and conflicting |
| Lower-body strength in older adults | Possibly yes, with loading | Moderate, subgroup only |
| Brain creatine concentration | Yes, higher and longer dosing raises it more | Moderate, small samples, ceiling under 10% |
| Cognition, healthy and well-rested | No. Directly tested at 10 and 20 g, null. | One 6-week RCT, n = 30 |
| Cognition under acute stress (sleep loss, hypoxia) | Yes, as a single acute dose | Two crossover trials, n = 15 and 29 |
Safe and Tolerable Are Two Different Questions
Superdosing critics reach for kidney damage, and that argument is weak. Lugaresi et al. (2013) put resistance-trained men on a high-protein diet through 20 g/day loading plus 5 g/day for 12 weeks and measured glomerular filtration rate directly with 51Cr-EDTA clearance. No change. Kreider et al. (2003) tracked 98 Division I football players for up to 21 months on 5 to 10 g/day across a 69-marker panel of blood and urine chemistry and found nothing. The ISSN position stand (Kreider et al., 2017) concluded that doses up to 30 g/day for five years are safe and well tolerated across populations from infants to the elderly.
One practical note: creatine supplementation raises serum creatinine, which is the marker most labs use to estimate kidney function. That is a measurement artifact, not kidney injury. Tell your doctor you supplement before anyone panics about an eGFR.
So safety is not the problem. Tolerability is.
Ostojic and Ahmetovic (2008) gave 59 elite soccer players 10 g/day for 28 days, either as two 5 g doses or one 10 g dose. Total daily intake was identical. The single-serving group had significantly more diarrhea. Creatine is osmotically active; what your gut does not absorb pulls water into the lumen and speeds transit. Serving size, not daily total, is what drives the GI response.
The most instructive data point on chronic superdosing comes from neurology. CREST-E (Hersch et al., 2017) put early-stage Huntington disease patients on up to 40 g/day for as long as 48 months. The trial was halted for futility, the decline rate slightly favored placebo, and withdrawal was higher in the creatine arm driven by gastrointestinal adverse events. Forty grams a day is not dangerous. It is just genuinely unpleasant enough that sick, motivated people in a funded clinical trial quit.
What We Actually Tell Clients
Match the dose to the target, and be honest about which claims have evidence behind them.
| Goal | Protocol | Evidence grade |
|---|---|---|
| Muscle saturation, strength, hypertrophy | 3-5 g/day, or 0.03-0.05 g/kg/day for very large or very small athletes | Strong |
| Fast saturation before a meet or camp | 20 g/day split into 4 x 5 g for 5-7 days, then back to maintenance | Strong |
| General brain-health hedge | 10 g/day, split into 2 x 5 g | Plausible mechanism, unproven outcome |
| Known acute cognitive stress: overnight flight, night shift, deliberate sleep restriction | Single 0.2-0.35 g/kg dose (roughly 14-25 g), taken with food, ideally split | Two small crossover RCTs |
| Chronic 20-25 g/day for cognition | Not supported | Directly tested at 20 g for 6 weeks; null |
The 10 g/day recommendation deserves a specific caveat. It is a defensible hedge, not a proven protocol. The reasoning is that brain uptake is slow and dose-limited, so more input plausibly means more brain creatine, and Kondo et al. saw the largest frontal phosphocreatine rise in the 10 g arm. But that finding was not statistically significant, and the one trial that ran 10 g against placebo for cognitive outcomes in healthy adults found nothing. If you take 10 g, take it knowing you are buying a mechanism, not a result.
And whatever the daily total, never take more than 5 g in a single serving. That is the one rule the data are unambiguous about.
Limitations
The brain trials are tiny. Dechent had six subjects. Turner had fifteen. Gordji-Nejad had fifteen, then twenty-nine. Moriarty had thirty split across three arms. These are not sample sizes that settle arguments in either direction, and the null results are as underpowered as the positive ones.
Nobody has run the actual experiment. There is no randomized trial of 20 to 25 g/day for months in healthy adults with meaningful cognitive endpoints. The recommendation that is spreading is an extrapolation from acute-stress studies to chronic use, which is exactly the inference type that has failed repeatedly in supplement science.
Brain creatine measurement is technically hard. MRS quantification of total creatine is region-dependent and noisy, and creatine is conventionally used as an internal reference peak in MRS, which creates real methodological headaches when creatine itself is the variable you are changing.
Publication and enthusiasm bias. Creatine is having a cultural moment. Positive brain findings get press releases and podcast segments. The Moriarty null result got neither, and I had to go looking for it.
Population mismatch. The memory benefit in the meta-analytic data concentrates in adults aged 66 to 76 and in populations under metabolic stress. If you are a well-rested 30-year-old who sleeps eight hours, you are not the population where these effects have been demonstrated.
The muscle literature is unsettled at the margins. Desai et al. (2025) found no lean mass advantage from 5 g/day over 12 weeks of training once the water shift was separated out, which is a genuine challenge to the consensus and cuts against easy confidence in either direction.
Practical Takeaways
Keep taking 3 to 5 g/day for training. The muscle ceiling is real, it is old news, and nothing in the brain literature changes the muscle answer.
Scale by body mass, not by hype. Use 0.03 to 0.05 g/kg/day if you are much larger or smaller than average. A 110 kg athlete taking 3 g is arguably underdosed; a 60 kg athlete taking 25 g is throwing money away.
Never exceed 5 g in one serving. Serving size drives the diarrhea risk, not daily total (Ostojic and Ahmetovic, 2008). If you go above 5 g/day, split it.
Treat 25 g as a tool for a specific bad night, not a daily habit. The evidence supports a single high dose under acute sleep deprivation. It does not support a permanent five-scoop routine.
If you try 10 g/day, run it as an experiment with a defined endpoint. Pick 12 weeks, track e1RM trends and session quality in Verro, and decide in advance what would count as a result. Vague self-assessment will confirm whatever you already believe.
Tell your doctor you supplement before your next blood panel. Elevated serum creatinine on creatine is an artifact, and it has sent plenty of healthy people down an unnecessary workup.
Spend the marginal effort on sleep instead. The best-supported creatine-for-brain finding is that it partially rescues cognition when you are sleep deprived. Not being sleep deprived beats the rescue dose every time.
This is the same pattern we found when we looked at ashwagandha and performance in an earlier post: a real mechanism, a handful of small studies, a marketing narrative that runs several years ahead of the data, and a population of already-trained, already-rested people who are the least likely to see the advertised effect. Creatine has vastly better evidence than ashwagandha for its core use. That is precisely why the extension claims deserve scrutiny rather than a free pass.
References
| Citation (APA) | Study Type | Why It Matters | Supports This Claim |
|---|---|---|---|
| Harris, R.C., Soderlund, K., & Hultman, E. (1992). Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clinical Science, 83(3), 367-374. | Experimental (muscle biopsy) | The original human loading study; established that oral creatine raises muscle stores at all | Muscle total creatine rises roughly 20-25 mmol/kg dry mass with repeated 5 g doses |
| Hultman, E., Soderlund, K., Timmons, J.A., Cederblad, G., & Greenhaff, P.L. (1996). Muscle creatine loading in men. Journal of Applied Physiology, 81(1), 232-237. | RCT (muscle biopsy) | Directly compared loading plus low maintenance against low dose alone; both reached the same concentration | Dose changes the speed of saturation, not the ceiling; 3 g/day for 28 days equals 20 g/day loading |
| Braissant, O. (2012). Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers. Journal of Inherited Metabolic Disease, 35(4), 655-664. | Review | Explains why brain creatine behaves differently from muscle creatine | The blood-brain barrier has limited creatine permeability and the brain synthesizes much of its own |
| Dechent, P., Pouwels, P.J., Wilken, B., Hanefeld, F., & Frahm, J. (1999). Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. American Journal of Physiology, 277(3), R698-R704. | Experimental (1H-MRS) | The foundational measurement of brain creatine response to a high oral dose | 20 g/day for four weeks raises brain total creatine only about 8.7 percent, with strong regional variation |
| Turner, C.E., Byblow, W.D., & Gant, N. (2015). Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation. Journal of Neuroscience, 35(4), 1773-1780. | RCT (crossover) | Pairs a measured 9.2 percent brain creatine rise with a functional outcome, but only under hypoxia | High-dose creatine protects cognition under an acute metabolic stressor, not at rest |
| Kondo, D.G., Forrest, L.N., Shi, X., Sung, Y.-H., Hellem, T.L., Huber, R.S., & Renshaw, P.F. (2016). Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression. Amino Acids, 48(8), 1941-1954. | RCT (dose-ranging, 31P-MRS) | The only true brain dose-ranging trial: 2 g vs 4 g vs 10 g vs placebo over 8 weeks | Frontal phosphocreatine rose most at 10 g (+9.1 percent) but the dose-response was not significant (p = 0.69) |
| Gordji-Nejad, A., Matusch, A., Kleedorfer, S., Patel, H.J., Drzezga, A., Elmenhorst, D., Binkofski, F., & Bauer, A. (2024). Single dose creatine improves cognitive performance and induces changes in cerebral high energy phosphates during sleep deprivation. Scientific Reports, 14, 4937. | RCT (crossover, n = 15) | The study the entire 25 g claim rests on; a single 0.35 g/kg dose during 21 hours of sleep deprivation | The 25 g finding is an acute single-dose rescue under stress, not a daily protocol |
| Gordji-Nejad, A., Matusch, A., Hengstler, L., Beer, S., Kroll, T., Klein, S., Elmenhorst, D., Bauer, A., & Drzezga, A. (2026). Single-dose creatine reduces sleep deprivation-induced deterioration in cognitive performance. Nutrients, 18(8), 1192. | RCT (crossover, n = 29) | Larger replication at a lower single dose of 0.2 g/kg | The acute effect replicates, and at roughly 14 g rather than 25 g for a 70 kg person |
| Moriarty, T., Bourbeau, K., Dorman, K., Runyon, L., Glaser, N., Brandt, J., Hoodjer, M., Forbes, S.C., & Candow, D.G. (2023). Dose-response of creatine supplementation on cognitive function in healthy young adults. Brain Sciences, 13(9), 1276. | RCT (3-arm, 6 weeks) | The only direct chronic test of 10 g vs 20 g vs placebo on cognition in healthy young adults | Neither 10 g nor 20 g daily improved cognition or prefrontal activation; no dose-response |
| Prokopidis, K., Giannos, P., Triantafyllidis, K.K., Kechagias, K.S., Forbes, S.C., & Candow, D.G. (2023). Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 81(4), 416-427. | Meta-analysis (8 RCTs) | Pooled memory effect is small (SMD 0.29) with high heterogeneity; a published letter to the editor alleges double-counting inflated it | Dose from 2.2 to 20 g/day did not moderate the memory effect; benefit concentrated in adults aged 66-76 |
| Forbes, S.C., Candow, D.G., Ostojic, S.M., Roberts, M.D., & Chilibeck, P.D. (2021). Meta-analysis examining the importance of creatine ingestion strategies on lean tissue mass and strength in older adults. Nutrients, 13(6), 1912. | Meta-analysis | The clearest dose comparison for body composition and strength outcomes | Higher dose (>5 g/day) helped leg press strength; lean mass gains were equal or slightly better at 5 g/day or less |
| Desai, I., Pandit, A., Smith-Ryan, A.E., Simar, D., Candow, D.G., Kaakoush, N.O., & Hagstrom, A.D. (2025). The effect of creatine supplementation on lean body mass with and without resistance training. Nutrients, 17(6), 1081. | RCT (n = 63, 13 weeks) | Used a 7-day wash-in to separate the fluid shift from real tissue accrual, a design most prior trials lacked | 5 g/day added nothing to 12 weeks of supervised training; the authors suggest more than 5 g/day may be needed |
| Antonio, J., Candow, D.G., Forbes, S.C., Gualano, B., Jagim, A.R., Kreider, R.B., Rawson, E.S., Smith-Ryan, A.E., VanDusseldorp, T.A., Willoughby, D.S., & Ziegenfuss, T.N. (2021). Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? Journal of the International Society of Sports Nutrition, 18(1), 13. | Review | Consensus statement from the researchers who run most of this literature | Loading is unnecessary; 3-5 g/day is sufficient to saturate muscle and support performance |
| Kreider, R.B., Kalman, D.S., Antonio, J., Ziegenfuss, T.N., Wildman, R., Collins, R., Candow, D.G., Kleiner, S.M., Almada, A.L., & Lopez, H.L. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 14, 18. | Position stand | The reference safety document for creatine dosing | Up to 30 g/day for five years is safe and well tolerated across populations |
| Kreider, R.B., Melton, C., Rasmussen, C.J., Greenwood, M., Lancaster, S., Cantler, E.C., Milnor, P., & Almada, A.L. (2003). Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Molecular and Cellular Biochemistry, 244(1-2), 95-104. | Longitudinal (21 months, n = 98) | The longest-running clinical marker panel in athletes on creatine | Sustained 5-10 g/day produced no adverse change across a 69-marker blood and urine panel |
| Lugaresi, R., Leme, M., de Salles Painelli, V., Murai, I.H., Roschel, H., Sapienza, M.T., Lancha Junior, A.H., & Gualano, B. (2013). Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet? Journal of the International Society of Sports Nutrition, 10, 26. | RCT (direct GFR measurement) | Measured glomerular filtration rate directly with 51Cr-EDTA rather than inferring it from serum creatinine | Loading plus 12 weeks of creatine on a high-protein diet did not alter kidney function |
| Ostojic, S.M., & Ahmetovic, Z. (2008). Gastrointestinal distress after creatine supplementation in athletes: are side effects dose dependent? Research in Sports Medicine, 16(1), 15-22. | RCT (n = 59) | Held the daily total constant at 10 g and varied only the serving size | A single 10 g serving significantly increased diarrhea versus two 5 g servings; serving size drives GI risk |
| Hersch, S.M., Schifitto, G., Oakes, D., Bredlau, A.-L., Meyers, C.M., Nahin, R., & Rosas, H.D. (2017). The CREST-E study of creatine for Huntington disease: A randomized controlled trial. Neurology, 89(6), 594-601. | RCT (phase III, up to 48 months) | The largest and longest trial of genuinely superdosed creatine in humans, at up to 40 g/day | Chronic superdosing is not dangerous but is poorly tolerated; GI adverse events drove higher withdrawal |
| Candow, D.G., Ostojic, S.M., Chilibeck, P.D., Longobardi, I., Gualano, B., Tarnopolsky, M.A., Wallimann, T., Moriarty, T., Kreider, R.B., Forbes, S.C., Schlattner, U., & Antonio, J. (2025). Creatine monohydrate supplementation for older adults and clinical populations. Journal of the International Society of Sports Nutrition, 22(sup1), 2534130. | Review | The most recent expert synthesis, from the group most associated with the higher-dose argument | Brain benefits require higher and longer dosing, and the biodynamics above 20 g/day remain unknown |
DISCLAIMER
This article is for educational purposes only and is not intended as medical or nutritional advice. Creatine monohydrate is one of the best-studied supplements in existence and has a strong safety record, but the specific high-dose protocols discussed here sit at the edge of the evidence base, and several are extrapolations from acute laboratory studies rather than tested daily regimens.
Individual response to creatine varies substantially, and roughly one in four people shows little measurable change at any dose. Gastrointestinal tolerance in particular is highly individual and dose-per-serving dependent. If you have kidney disease, are on medications that affect renal function, are pregnant or nursing, or are considering doses above 5 g/day, consult a qualified healthcare professional before starting. Tell whoever orders your bloodwork that you supplement, because creatine elevates serum creatinine without impairing kidney function.
At Verro, we treat supplementation as one small input in a much larger training picture, not as a lever that substitutes for progressive overload, adequate protein, sufficient sleep, and a well-designed program. If you are debating between 5 g and 25 g of creatine while sleeping six hours a night, you are optimizing the wrong variable.